HIGHLIGHTS
- who: Alina Scridon and Alkora Ioana Balan from the Physiology Department, University of Medicine, Pharmacy, Science and Technology "George Emil Palade" of have published the research work: Targeting Myocardial Fibrosis—A Magic Pill in Cardiovascular Medicine?, in the Journal: Pharmaceutics 2022, 14, 1599. of /2022/
- future: The authors also emphasize a number of questions that remain to be answered and the authors identify hotspots for future research. Some studies suggested that β2Ars-mediated signaling could be cardioprotective but in others non-specific βARs stimulation with isoproterenol and transgenic overexpression of β2ARs were highly profibrotic leaving . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.